FR2397838A1 - Preparation de gamma globuline naturelle lyophilisee pour administration intraveineuse - Google Patents

Preparation de gamma globuline naturelle lyophilisee pour administration intraveineuse

Info

Publication number
FR2397838A1
FR2397838A1 FR7817929A FR7817929A FR2397838A1 FR 2397838 A1 FR2397838 A1 FR 2397838A1 FR 7817929 A FR7817929 A FR 7817929A FR 7817929 A FR7817929 A FR 7817929A FR 2397838 A1 FR2397838 A1 FR 2397838A1
Authority
FR
France
Prior art keywords
gamma globulin
preparation
intravenous administration
natural
lyophilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7817929A
Other languages
English (en)
Other versions
FR2397838B1 (fr
Inventor
Masayuki Nishida
Sadao Yabushita
Shigeru Fujita
Toshiyuki Saki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of FR2397838A1 publication Critical patent/FR2397838A1/fr
Application granted granted Critical
Publication of FR2397838B1 publication Critical patent/FR2397838B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention a pour objet une préparation de gamma globuline naturelle lyophilisée pour administration intraveineuse Cette préparation comprend une gamma globuline naturelle humaine ayant une activité anticomplémentaire de 20 (C'H50) ou moins, et 0,06 à 0,26 (inclus) partie en poids d'un sel minéral neutre par partie en poids de gamma globuline. Utilisation de la préparation de gamma globuline lyophilisée pour administration par voie intraveineuse.
FR7817929A 1977-07-19 1978-06-15 Preparation de gamma globuline naturelle lyophilisee pour administration intraveineuse Granted FR2397838A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52087128A JPS5822085B2 (ja) 1977-07-19 1977-07-19 静注用ガンマ・グロブリン製剤

Publications (2)

Publication Number Publication Date
FR2397838A1 true FR2397838A1 (fr) 1979-02-16
FR2397838B1 FR2397838B1 (fr) 1981-11-27

Family

ID=13906314

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7817929A Granted FR2397838A1 (fr) 1977-07-19 1978-06-15 Preparation de gamma globuline naturelle lyophilisee pour administration intraveineuse

Country Status (17)

Country Link
US (1) US4168303A (fr)
JP (1) JPS5822085B2 (fr)
AT (1) AT359640B (fr)
BE (1) BE868233A (fr)
CA (1) CA1093965A (fr)
CH (1) CH639854A5 (fr)
DE (1) DE2827027C3 (fr)
DK (1) DK274178A (fr)
ES (1) ES470855A1 (fr)
FR (1) FR2397838A1 (fr)
GB (1) GB2001325B (fr)
HK (1) HK9584A (fr)
LU (1) LU79846A1 (fr)
NL (1) NL7806486A (fr)
PT (1) PT68199A (fr)
SE (1) SE443717B (fr)
ZA (1) ZA783303B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
JPS55164630A (en) * 1979-06-11 1980-12-22 Green Cross Corp:The Freeze-dried preparation of anti-hbs globulin
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
US4499073A (en) * 1981-08-24 1985-02-12 Cutter Laboratories, Inc. Intravenously injectable immune serum globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
JPS5855432A (ja) * 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
EP0085747B2 (fr) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Immunoglobuline humaine pour administration intraveineuse et son procédé de préparation
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
US4719290A (en) * 1983-09-02 1988-01-12 Armour Pharmaceutical Corporation Composition of intravenous immune globulin
GB8406560D0 (en) * 1984-03-13 1984-04-18 Central Lab Of The Blood Donor Organic compounds
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
EP0445108A1 (fr) * 1986-03-10 1991-09-11 RUBINSTEIN, Alan I. Procede de traitement de gammaglobuline
EP0465513A1 (fr) * 1989-03-27 1992-01-15 Centocor, Inc. COMPOSITIONS SERVANT A STABILISER DES ANTICORPS D'IMMUNOGLOBULINE IgM
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
US6165467A (en) * 1991-07-20 2000-12-26 Yoshihide Hagiwara Stabilized human monoclonal antibody preparation
TW200539855A (en) * 2004-03-15 2005-12-16 Wyeth Corp Calicheamicin conjugates
JP5322405B2 (ja) * 2007-06-07 2013-10-23 小林製薬株式会社 タンパク質含有組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79841C (da) * 1952-08-04 1955-09-12 Behringwerke Ag Fremgangsmåde til fremstilling af stabile γ-globulinpræparater.
DE959127C (de) * 1955-03-29 1957-02-28 Schering Ag Verfahren zur Gewinnung salzfreier, leicht loeslicher Trockenpraeparate von Proteinen, insbesondere Globulinen
US3966906A (en) * 1961-10-11 1976-06-29 Behringwerke Aktiengesellschaft Disaggregated gamma globulin and process for preparing it
DE1148037B (de) * 1961-10-11 1963-05-02 Behringwerke Ag Verfahren zur Herstellung eines desaggregierten, das Komplementsystem nicht beeinflussenden Gammaglobulins
US3466368A (en) * 1967-06-02 1969-09-09 Us Health Education & Welfare Cleavage of human gamma globulin by means of cyanogen bromide
IL34079A (en) * 1969-04-01 1973-02-28 Upjohn Co Purification of ypsilon-globulins
US3607858A (en) * 1970-03-31 1971-09-21 American Cyanamid Co Process for preparing lyophilized human blood proteins such as gamma globulin in the presence of a nonionic surfactant
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
US3850903A (en) * 1973-06-21 1974-11-26 S Mankarious Plasma volume expander prepared from cohn iv precipitate using block copolymers of ethylene oxide and polyoxypropylene
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
CA1064396A (fr) * 1975-02-18 1979-10-16 Myer L. Coval Precipitation fractionnee de la gamma globuline a l'aide de polyethylene glycol
GB1499035A (en) * 1975-04-10 1978-01-25 Ts Nii Gematologii I Perelivan Antistaphylococcus human immune globulin and method of preparing same
US4021540A (en) * 1975-07-28 1977-05-03 Ortho Diagnostics Inc. Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material
FR2336141A1 (fr) * 1975-12-23 1977-07-22 Trepo Christian Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン

Also Published As

Publication number Publication date
NL7806486A (nl) 1979-01-23
SE7807040L (sv) 1979-01-20
JPS5423115A (en) 1979-02-21
BE868233A (fr) 1978-10-16
GB2001325A (en) 1979-01-31
FR2397838B1 (fr) 1981-11-27
GB2001325B (en) 1982-03-17
HK9584A (en) 1984-02-10
ZA783303B (en) 1979-07-25
AT359640B (de) 1980-11-25
CH639854A5 (de) 1983-12-15
ES470855A1 (es) 1979-02-01
DE2827027A1 (de) 1979-01-25
ATA441378A (de) 1980-04-15
JPS5822085B2 (ja) 1983-05-06
DE2827027C3 (de) 1987-04-16
DE2827027B2 (de) 1979-12-20
LU79846A1 (fr) 1978-12-07
SE443717B (sv) 1986-03-10
US4168303A (en) 1979-09-18
DK274178A (da) 1979-01-20
CA1093965A (fr) 1981-01-20
PT68199A (en) 1978-07-01

Similar Documents

Publication Publication Date Title
FR2397838A1 (fr) Preparation de gamma globuline naturelle lyophilisee pour administration intraveineuse
MX9708780A (es) Nuevos heterociclos como inhibidores de la adhesion de leucocitos y antagonistas de vla-4.
NO865140L (no) Fortykningsmiddel for matvarer og for, samt fremgangsmaate for fremstilling av et slikt.
FR2380266A1 (fr) Molybdates d'amines heterocycliques, procede d'obtention et application
DK162222C (da) 2-amino-5-hydroxy-4-methylpyrimidin-derivater og farmeceutiske praeparater indeholdende disse
FI831230L (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
NO852567L (no) Thymopentinanaloger og fremgangsmmaate for deres fremstilling.
WO1979000853A1 (fr) Produit medicinal pour organe circulatoire
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
DE3684211D1 (fr)
NL7804815A (nl) Bereiding van geconcentreerde bacteriecultures voor "direct-vat-set" kaasbereiding.
DE69528074D1 (de) Chitosan induzierte verstärkung
MD423C2 (ro) Procedeu de obţinere a delmopionului, compuşi intermediari pentru efectuarea procedeului
ES8601942A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
EP0317953A3 (fr) N-(1-Tihénylcycloalkyl)-alkényl-amines pour le traitement de maladies neurotoxiques
MY131024A (en) Immunostimulating 6-aryl-5, 6-dihydroimidazo [2,1-b] thiazole derivatives.
ES455133A1 (es) Un procedimiento de preparacion de 17-esteres de 17-alfa-hi-droxi-gestogenos.
ES2017982B3 (es) Liofilizado de ifosfamida y procedimiento para su preparacion.
EP0299050A4 (fr) Isolement a partir de fluide folliculaire de proteines a chaine unique avec activite de suppression de la fsh.
JPS56118082A (en) Aldehyde adduct of novel 2*4*77triaminoo66phenylbutelidine
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
BG47034A3 (en) Method for preparing of 7- /meta- substituted/- phenylglycine- 1- carba- 1- dithiacephalosporines
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
FR2443464A1 (fr) Derives d'acides thiadiazole-1,3,4 carboxyliques-2 et produits fongicides et nematicides qui en contiennent

Legal Events

Date Code Title Description
ST Notification of lapse